HIV-associated pruritus: Etiology and management

American Journal of Clinical Dermatology

Volumn 4, Issue 3, 2003, Pages 177-188

  Singh, Fiza ^a   Rudikoff, Donald ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMMONIUM LACTATE; ANTIPRURITIC AGENT; BIFONAZOLE; CEFALEXIN; CHLORHEXIDINE GLUCONATE; CIPROFLOXACIN; CLINDAMYCIN; CORTICOSTEROID; COTRIMOXAZOLE; DICLOXACILLIN; ETANERCEPT; ETRETINATE; HYDROXYUREA; ISOTRETINOIN; ITRACONAZOLE; IVERMECTIN; KETOCONAZOLE; LANOLIN ALCOHOL; LINDANE; MALATHION; METHOTREXATE; METRONIDAZOLE; PERMETHRIN; PIMECROLIMUS; PSEUDOMONIC ACID; PSORALEN; RETINOID; TACROLIMUS; THALIDOMIDE; UNINDEXED DRUG; XIPAMIDE;

ATOPIC DERMATITIS; CLINICAL FEATURE; DISEASE COURSE; DRUG ERUPTION; DRUG HYPERSENSITIVITY; DRUG INDICATION; FOLLICULITIS; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; METABOLIC DISORDER; OPPORTUNISTIC INFECTION; PHOTOTHERAPY; PRIORITY JOURNAL; PRURITUS; PSORIASIS; PUBIC PEDICULOSIS; PUVA; REVIEW; SEBORRHEIC DERMATITIS; STAPHYLOCOCCUS INFECTION;

AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTIPRURITICS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; DERMATOMYCOSES; FEMALE; HUMANS; INCIDENCE; MALE; PROGNOSIS; PRURITUS; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; SKIN DISEASES, BACTERIAL; SKIN DISEASES, VIRAL;

EID: 0037241075     PISSN: 11750561     EISSN: None     Source Type: Journal    
DOI: 10.2165/00128071-200304030-00004     Document Type: Review

References (96)

1. Wong T, Chiasson MA, Reggy A, et al. Antiretroviral therapy and declining AIDS mortality in New York City. J Urban Health 2000: 77:492-500
2. Gelfand JM, Rudikoff D. Evaluation and treatment of itching in HIV-infected patients. Mt Sinai J Med 2001; 68: 298-308
3. Greaves MW, Wall PD. Pathophysiology of itching. Lancet 1996; 348: 938-40
4. Friedler S, Parisi MT, Waldo E, et al. Atypical cutaneous lymphoproliferative disorder in patients with HIV infection. Int J Dermatol 1999; 38: 111-8
5. Smith RJ, Skelton HG, Yeager J, et al. Increased drug reactions in HIV-I-positive patients: a possible explanation based on patterns of immune dysregulation seen in HIV-1 disease. Clin Exp Dermatol 1997; 22: 118-23
6. Gajewski LK, Grimone AJ, Melbourne KM, et al. Characterization of rash with indinavir in a national patient cohort. Ann Pharmacother 1999; 33: 17-21
7. Szczech LA. Renal diseases associated with human immunodeficiency virus infection: epidemiology, clinical course, and management. Clin Infect Dis 2001; 33:115-9
8. Bonacini M. Pruritus in patients with chronic human immunodeficiency virus. hepatitis B and C virus infections. Dig Liver Dis 2000; 32: 621-5
9. Prakash M, Poreddy V, Tiyyagura L, et al. Jaundice and hepatocellular damage associated with nevirapine therapy. Am J Gastroenterol 2001; 96: 1571-4
10. Lambert M. Thyroid dysfunction in HIV infection. Baillieres Clin Endocrinol Metab 1994; 8: 825-35
11. Gabarre J, Raphael M, Lepage E, et al. Human immunodeficiency virus-related lymphoma: relation between clinical features and histologic subtypes. Am J Med 2001; 111: 704-11
12. Palella Jr FJ, Delaney KM, Moorman AC, et al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators. N Engl J Med 1998; 338: 853-60
13. Handa S, Bingham JS. Dermatological immune restoration syndrome: does it exist? J Eur Acad Dermatol Venereol 2001; 15: 430-2
14. Bachmeyer C, Cordier F, Cazier A, et al. Eosinophilic folliculitis associated with AIDS after antiretroviral tri-therapy. Presse Med 1999; 28: 2226
15. Shimizu S, Chen KR, Tagami H, et al. Mucocutaneous manifestations in Japanese HIV-positive hemophiliacs. Dermatology 2000; 201: 321-5
16. Arlian LG, Estes SA, Vyszenski-Moher DL. Prevalence of Sarcoptes scabiei in the homes and nursing homes of scabietic patients. J Am Acad Dermatol 1988; 19: 806-11
17. Dourmishev A, Serafimova D, Dourmishev L. Efficacy and tolerance of oral ivermectin in scabies. J Eur Acad Dermatol Venereol 1998; 11: 247-51
18. Usha V, Gopalakrishnan Nair TV. A comparative study of oral ivermectin and topical permethrin cream in the treatment of scabies. J Am Acad Dermatol 2000; 42: 236-40
19. Burkhart CN, Burkhart CG. Ivermectin: a few caveats are warranted before initiating therapy for scabies. Arch Dermatol 1999; 135: 1549-50
20. Cone LA, Woodard DR, Byrd RG, et al. A recalcitrant, erythematous, desquamating disorder associated with toxin-producing staphylococci in patients with AIDS. J Infect Dis 1992; 165: 638-43
21. Raviglione MC, Mariuz P, Pablos-Mendez A, et al. High Staphylococcus aureus nasal carriage rate in patients with acquired immunodeficiency syndrome or AIDS-related complex. Am J Infect Control 1990; 18: 64-9
22. Holbrook KA, Klein RS, Hartel D, et al. Staphylococcus aureus nasal colonization in HIV-seropositive and HIV-seronegative drug users. J Acquir Immune Defic Syndr Hum Retrovirol 1997; 16: 301-6
23. Martin JN, Perdreau-Remington F, Kartalija M, et al. A randomized clinical trial of mupirocin in the eradication of Staphylococcus aureus nasal carriage in human immunodeficiency virus disease. J Infect Dis 1999; 180: 896-9
24. Cockerell CJ. Seborrheic dermatitis-like and atopic dermatitis-like eruptions in HIV-infected patients. Clin Dermatol 1991; 9: 49-51
25. Rudikoff D. The relationship between HIV infection and atopic dermatitis. Curr Allergy Asthma Rep 2002; 2: 275-81
26. Lin RY, Lazarus TS. Asthma and related atopic disorders in outpatients attending an urban HIV clinic. Ann Allergy Asthma Immunol 1995; 74: 510-5
27. Lin RY. Chronic diffuse dermatitis and hyper-IgE in HIV infection. Acta Derm Venereol 1988; 68: 486-91
28. Paganelli R, Scala E, Mezzaroma I, et al. Immunologic aspects of hyper-immunoglobulinemia E-like syndrome in patients with AIDS. J Allergy Clin Immunol 1995; 95: 995-1003
29. Nissen D, Nolte H, Permin H, et al. Evaluation of IgE-sensitization to fungi in HIV-positive patients with eczematous skin reactions. Ann Allergy Asthma Immunol 1999; 83: 153-9
30. Solinger AM, Hess EV. Rheumatic diseases and AIDS: is the association real? J Rheumatol 1993; 20: 678-83
31. Duvic M, Johnson TM, Rapini RP, et al. Acquired immunodeficiency syndrome-associated psoriasis and Reiter's syndrome. Arch Dermatol 1987; 123: 1622-32
32. Morar N, Dlova N, Gupta AK, et al. Erythroderma: a comparison between HIV positive and negative patients. Int J Dermatol 1999; 38: 895-900
33. Mallon E, Young D, Bunce M, et al. HLA-Cw*0602 and HIV-associated psoriasis. Br J Dermatol 1998; 139: 527-33
34. Fischer T, Schworer H, Vente C, et al. Clinical improvement of HIV-associated psoriasis parallels a reduction of HIV viral load induced by effective antiretroviral therapy. AIDS 1999; 13: 628-9
35. Duvic M, Crane MM, Conant M, et al. Zidovudine improves psoriasis in human immunodeficiency virus-positive males. Arch Dermatol 1994; 130: 447-51
36. Kaplan MH, Sadick NS, Wieder J, et al. Antipsoriatic effects of zidovudine in human immunodeficiency virus-associated psoriasis. J Am Acad Dermatol 1989; 20: 76-82
37. Ruzicka T, Froschl M, Hohenleutner U, et al. Treatment of HIV-induced retinoid-resistant psoriasis with zidovudine. Lancet 1987; I1: 1469-70
38. Akaraphanth R, Lim HW, HIV, UV and immunosuppression. Photdermatol Photoimmunol Photomed 1999; 15: 28-31
39. Morrey JD, Bourn SM, Bunch TD, et al. In vivo activation of human immunodeficiency virus type I long terminal repeat by UV type A (UV-A) light plus psoralen and UV-B light in the skin of transgenic mice. J Virol 1991; 65: 5045-51
40. Gelfand JM, Rudikoff D, Lebwohl M, et al. Effect of UV-B phototherapy on plasma HIV type 1 RNA viral level: a self-controlled prospective study. Arch Dermatol 1998; 134: 940-5
41. Ranki A, Puska P, Mattinen S, et al. Effect of PUVA on immunologic and virologic findings in HIV-infected patients. J Am Acad Dermatol 1991; 24: 404-10
42. Pechere M, Yerly S, Lemonnier E, et al. Impact of PUVA therapy on HIV viremia: a pilot study. Dermatology 1997; 195: 84-5
43. Akaraphanth R, Lim HW, HIV, UV and immunosuppression. Photodermatol Photoimmunol Photomed 1999; 15: 28-31
44. Morison WL. PUVA therapy is preferable to UVB phototherapy in the management of HIV-associated dermatoses. Photochem Photobiol 1996; 64: 267-8
45. Stern RS, Nichols KT, Vakeva LH. Malignant melanoma in patients treated for psoriasis with methoxsalen (psoralen) and ultraviolet A radiation (PUVA): the PUVA follow-up study. N Engl J Med 1997; 336: 1041-5
46. Buccheri L, Katchen BR, Karter AJ, et al. Acitretin therapy is effective for psoriasis associated with human immunodeficiency virus infection. Arch Dermatol 1997; 133: 711-5
47. Maurer TA, Zackheim HS, Tuffanelli L, et al. The use of methotrexate for treatment of psoriasis in patients with HIV infection. J Am Acad Dermatol 1994; 31: 372-5
48. Thomas DR, Dover JS, Camp RD. Pancytopenia induced by the interaction between methotrexate and trimethoprim-sulfamethoxazole. J Am Acad Dermatol 1987; 17: 1055-6
49. Groenendal H, Rampen FH. Methotrexate and trimethoprim-sulphamethoxazole: a potentially hazardous combination. Clin Exp Dermatol 1990; 15: 358-60
50. Kumar B, Saraswat A, Kaur I. Rediscovering hydroxyurea: its role in recalcitrant psoriasis. Int J Dermatol 2001; 40: 530-4
51. Reisler K. High hepatotoxicity rate seen among HAART patients. Aids Alert 2001; 16: 118-9
52. Aboulafia DM, Bundow D, Wilske K, et al. Etanercept for the treatment of human immunodeficiency virus-associated psoriatic arthritis. Mayo Clin Proc 2000; 75: 1093-8
53. Matis WL, Triana A, Shapiro R, et al. Dermatologic findings associated with human immunodeficiency virus infection. J Am Acad Dermatol 1987; 17: 746-51
54. Berger RS, Stoner MF, Hobbs ER, et al. Cutaneous manifestations of early human immunodeficiency virus exposure. J Am Acad Dermatol 1988; 19: 298-303
55. Mirowski GW, Hilton JF, Greenspan D, et al. Association of cutaneous and oral diseases in HIV-infected men. Oral Dis 1998; 4: 16-21
56. Montella F, Pezzotti P, Di Sora F, et al. Improving the prognostic value of CD4+ count using IgA and clinical signs in HIV-seropositive IV drug users. Infection 1997; 25: 117-20
57. Mirmirani P, Hessol NA, Maurer TA, et al. Prevalence and predictors of skin disease in the Women's Interagency HIV Study (WIHS). J Am Acad Dermatol 2001; 44: 785-8
58. Ross S, Richardson MD, Graybill JR. Association between Malassezia furfur colonization and seborrhoeic dermatitis in AIDS patients. Mycoses 1994: 37: 367-70
59. Wikler JR, Nieboer C, Willemze R. Quantitative skin cultures of Pityrosporum yeasts in patients seropositive for the human immunodeficiency virus with and without seborrheic dermatitis. J Am Acad Dermatol 1992; 27: 37-9
60. Bergbrant IM. Seborrhoeic dermatitis and Pityrosporum yeasts. Curr Top Med Mycol 1995; 6: 95-112
61. Perniciaro C, Peters MS. Tinea faciale mimicking seborrheic dermatitis in a patient with AIDS. N Engl J Med 1986; 314: 315-6
62. Pirkhammer D, Seeber A, Honigsmann H, et al. Narrow-band ultraviolet B (ATL-01) phototherapy is an effective and safe treatment option for patients with severe seborrhoeic dermatitis. Br J Dermatol 2000; 143: 964-8
63. Bason MM, Berger TG, Nesbitt Jr LT. Pruritic papular eruption of HIV-disease. Int J Dermatol 1993; 32: 784-9
64. James WD, Redfield RR, Lupton GP, et al. A papular eruption associated with human T cell lymphotropic virus type III disease. J Am Acad Dermatol 1985; 13: 563-6
65. Colebunders R, Mann JM, Francis H, et al. Generalized papular pruritic eruption in African patients with human immunodeficiency virus infection. AIDS 1987; 1: 117-21
66. Liautaud B, Pape JW, DeHovitz JA, et al. Pruritic skin lesions: a common initial presentation of acquired immunodeficiency syndrome. Arch Dermatol 1989; 125: 629-32
67. Penneys NS, Nayar JK, Bernstein H, et al. Chronic pruritic eruption in patients with acquired immunodeficiency syndrome associated with increased antibody titers to mosquito salivary gland antigens. J Am Acad Dermatol 1989; 21: 421-5
68. Hevia O, Jimenez-Acosta F, Ceballos PI, et al. Pruritic papular eruption of the acquired immunodeficiency syndrome: a clinicopathologic study. J Am Acad Dermatol 1991: 24: 231-5
69. Soeprono FF, Schinella RA. Eosinophilic pustular folliculitis in patients with acquired immunodeficiency syndrome: report of three cases. J Am Acad Dermatol 1986; 14: 1020-2
70. Jenkins Jr D, Fisher BK, Chalvardjian A, et al. Eosinophilic pustular folliculitis in a patient with AIDS. Int J Dermatol 1988; 27: 34-5
71. Buchness MR, Lim HW, Hatcher VA, et al. Eosinophilic pustular folliculitis in the acquired immunodeficiency syndrome: treatment with ultraviolet B phototherapy. N Engl J Med 1988; 318: 1183-6
72. Rosenthal D, LeBoit PE, Klumpp L, et al. Human immunodeficiency virus-associated eosinophilic folliculitis: a unique dermatosis associated with advanced human immunodeficiency virus infection. Arch Dermatol 1991; 127: 206-9
73. McCalmont TH, Altemus D, Maurer T, et al. Eosinophilic folliculitis: the histologic spectrum. Am J Dermatopathol 1995; 17: 439-46
74. Ramos H. Erupcao papular pruritica associada ao virus da imunodeficiencia humana: etiopatogenese avaliada por analise clinica, imunohistoquimica e ultra-estructural. Rev Soc Bras Med Trop 1999; 32: 199-200
75. Rosatelli JB, Soares FA, Roselino AM. Pruritic papular eruption of the acquired immunodeficiency syndrome: predominance of CD8+ cells. Int J Dermatol 2000; 39: 873-4
76. Rosatelli JB, Roselino AM. Hyper-IgE, eosinophilia, and immediate cutaneous hypersensitivity to insect antigens in the pruritic papular eruption of human immunodeficiency virus. Arch Dermatol 2001; 137: 672-3
77. Boonchai W, Laohasrisakul R, Manonukul J, et al. Pruritic papular eruption in HIV seropositive patients: a cutaneous marker for immunosuppression. Int J Dermatol 1999; 38: 348-50
78. Aires JM, Rosatelli JB, de Castro Figueiredo JF, et al. Cytokines in the pruritic papular eruption of HIV. Int J Dermatol 2000; 39: 903-6
79. Reis ML, Maeda S, Rosatelli JB, et al. Kininogens and kallikrein in pruritic papular eruption. Immunopharmacology 1999; 45: 115-20
80. Colton AS, Schachner L, Kowalczyk AP. Eosinophilic pustular folliculitis. J Am Acad Dermatol 1986; 14: 469-74
81. Fearfield LA, Rowe A, Francis N, et al. Itchy folliculitis and human immunodeficiency virus infection: clinicopathological and immunological features, pathogenesis and treatment. Br J Dermatol 1999; 141: 3-11
82. Magro CM, Crowson AN. Necrotizing eosinophilic folliculitis as a manifestation of the atopic diathesis. Int J Dermatol 2000; 39: 672-7
83. Piantanida EW, Turiansky GW, Kenner JR, et al. HIV-associated eosinophilic folliculitis: diagnosis by transverse histologic sections. J Am Acad Dermatol 1998; 38: 124-6
84. Smith KJ, Skelton HG, Yeager J, et al. Metronidazole for eosinophilic pustular folliculitis in human immunodeficiency virus type 1-positive patients. Arch Dermatol 1995; 131: 1089-91
85. Berger TG, Heon V, King C, et al. Itraconazole therapy for human immunodeficiency virus-associated eosinophilic folliculitis. Arch Dermatol 1995; 131: 358-60
86. Otley CC, Avram MR. Johnson RA. Isotretinoin treatment of human immunodeficiency virus-associated eosinophilic folliculitis: results of an open, pilot trial. Arch Dermatol 1995; 131: 1047-50
87. Blauvelt A, Plott RT, Spooner K. et al. Eosinophilic folliculitis associated with the acquired immunodeficiency syndrome responds well to permethrin. Arch Dermatol 1995; 131: 360-1
88. Mattila JO, Vornanen M, Vaara J, et al. Mycobacteria in prurigo nodularis: the cause or a consequence? J Am Acad Dermatol 1996; 34: 224-8
89. Liang Y, Marcusson JA, Jacobi HH, et al. Histamine-containing mast cells and their relationship to NGFr-immunoreactive nerves in prurigo nodularis: a reappraisal. J Cutan Pathol 1998; 25: 189-98
90. Abadia Molina F, Burrows NP, Jones RR, et al. Increased sensory neuropeptides in nodular prurigo: a quantitative immunohistochemical analysis. Br J Dermatol 1992; 127: 344-51
91. Stander S, Luger T, Metze D. Treatment of prurigo nodularis with topical capsaicin. J Am Acad Dermatol 2001; 44: 471-8
92. Berger TG, Hoffman C, Thieberg MD. Prurigo nodularis and photosensitivity in AIDS: treatment with thalidomide. J Am Acad Dermatol 1995; 33: 837-8
93. Berger TG, Dhar A. Lichenoid photoeruptions in human immunodeficiency virus infection. Arch Dermatol 1994; 130: 609-13
94. Vin-Christian K, Epstein JH, Maurer TA, et al. Photosensitivity in HIV-infected individuals. J Dermatol 2000; 27: 361-9
95. Coldiron BM, Bergstresser PR. Prevalence and clinical spectrum of skin disease in patients infected with human immunodeficiency virus. Arch Dermatol 1989; 125: 357-61
96. Rowe A, Mallon E, Rosenberger P, et al. Depletion of cutaneous peptidergic innervation in HIV-associated xerosis. J Invest Dermatol 1999; 112: 284-9